Video

Baricitinib shows potential as lupus treatment

Publish date: June 15, 2018

 

REPORTING FROM THE EULAR 2018 CONGRESS

SOURCE: Wallace DJ et al. Ann Rheum Dis. 2018;77(Suppl 2):59. Abstract OP0019.

Pages

Recommended Reading

VIDEO: Characteristic flora define intestinal microbiome in scleroderma
MDedge Dermatology
New agents may bring hope for SLE patients
MDedge Dermatology
Caution crucial for stem cell transplant in scleroderma, despite potential interest
MDedge Dermatology
Don’t trust interface dermatitis to diagnose dermatomyositis
MDedge Dermatology
Median time to progression from discoid to systemic lupus may be less than a year
MDedge Dermatology
Timely dermatomyositis diagnosis, treatment remain elusive
MDedge Dermatology
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Dermatology
Cutaneous lupus: Switching antimalarials can delay immunosuppressive therapy
MDedge Dermatology
Long-term follow-up most important for hydroxychloroquine retinal screening
MDedge Dermatology
Pemphigus remission rate tops 80% with rituximab
MDedge Dermatology